RU98105169A - DERIVATIVES 8-AZABICYCLO [3.2.1] OCT-2-ENA, THEIR RECEIVING AND APPLICATION - Google Patents
DERIVATIVES 8-AZABICYCLO [3.2.1] OCT-2-ENA, THEIR RECEIVING AND APPLICATIONInfo
- Publication number
- RU98105169A RU98105169A RU98105169/04A RU98105169A RU98105169A RU 98105169 A RU98105169 A RU 98105169A RU 98105169/04 A RU98105169/04 A RU 98105169/04A RU 98105169 A RU98105169 A RU 98105169A RU 98105169 A RU98105169 A RU 98105169A
- Authority
- RU
- Russia
- Prior art keywords
- disorder
- disease
- azabicyclo
- oct
- disorders
- Prior art date
Links
- 201000010099 disease Diseases 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical group 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- WNTMTTVEDFGEMS-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]oct-3-ene Chemical compound C1=C(Cl)C(Cl)=CC=C1C(C1)=CC2NC1CC2 WNTMTTVEDFGEMS-UHFFFAOYSA-N 0.000 claims 2
- DDEYBFVSJXQKGW-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-ene Chemical compound CN1C(C2)CCC1C=C2C1=CC=C(Cl)C(Cl)=C1 DDEYBFVSJXQKGW-UHFFFAOYSA-N 0.000 claims 2
- HOMPRVJHQIRSOD-UHFFFAOYSA-N 3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-ene Chemical compound CN1C(C2)CCC1C=C2C1=CC=C(Cl)C=C1 HOMPRVJHQIRSOD-UHFFFAOYSA-N 0.000 claims 2
- 206010057666 Anxiety disease Diseases 0.000 claims 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 2
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- 210000003169 Central Nervous System Anatomy 0.000 claims 2
- 208000001652 Memory Disorders Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 206010052276 Pseudodementia Diseases 0.000 claims 2
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 claims 2
- 235000014632 disordered eating Nutrition 0.000 claims 2
- 201000006180 eating disease Diseases 0.000 claims 2
- 239000002858 neurotransmitter agent Substances 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 201000008430 obsessive-compulsive disease Diseases 0.000 claims 2
- 230000000697 serotonin reuptake Effects 0.000 claims 2
- 201000010874 syndrome Diseases 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- -1 3,4-methylenedioxyphenyl Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (11)
или любой из его энантиомеров либо любая их смесь, или его фармацевтически приемлемая соль,
где R представляет собой водород, алкил, алкенил, алкинил, циклоалкил, циклоалкилалкил или 2-гидроксиэтил;
R4 представляет собой фенил, который может быть замещен одним или более чем одним заместителем, выбранным из группы, состоящей из галогена, CF3, CN, алкоксила, циклоалкоксила, алкила, циклоалкила, алкенила, алкинила, аминогруппы, нитрогруппы, гетероарила и арила; 3,4-метилендиоксифенил; бензил, который может быть замещен одним или более чем одним заместителем, выбранным из группы, состоящей из галогена, CF3, CN, алкоксила, циклоалкоксила, алкила, циклоалкила, алкенила, алкинила, аминогруппы, нитрогруппы, гетероарила и арила; гетероарил, который может быть замещен одним или более чем одним заместителем, выбранным из группы, состоящей из галогена, СF3, CN, алкоксила, циклоалкоксила, алкила, циклоалкила, алкенила, алкинила, аминогруппы, нитрогруппы, гетероарила и арила; или нафтил, который может быть замещен одним или более чем одним заместителем, выбранным из группы, состоящей из галогена, CF3, CN, алкоксила, циклоалкоксила, алкила, циклоалкила, алкенила, алкинила, аминогруппы, нитрогруппы, гетероарила и арила.1. The compound having the formula
or any of its enantiomers, or any mixture thereof, or a pharmaceutically acceptable salt thereof,
where R represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl;
R 4 is phenyl, which may be substituted by one or more substituents selected from the group consisting of halogen, CF 3 , CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; 3,4-methylenedioxyphenyl; benzyl, which may be substituted by one or more substituents selected from the group consisting of halogen, CF 3 , CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; heteroaryl, which may be substituted by one or more substituents selected from the group consisting of halogen, CF 3 , CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; or naphthyl, which may be substituted by one or more substituents selected from the group consisting of halogen, CF 3 , CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl.
(+)-3-(3,4-дихлорфенил)-8-метил-8-азабицикло[3.2.1]окт-2-ен,
(+)-3-(4-хлорфенил)-8-метил-8-азабицикло[3.2.1]окт-2-ен или
(+)-3-(3,4-дихлорфенил)-8-азабицикло[3.2.1]окт-2-ен
либо их фармацевтически приемлемая соль присоединения.2. The compound according to claim 1, which is
(+) - 3- (3,4-dichlorophenyl) -8-methyl-8-azabicyclo [3.2.1] oct-2-ene,
(+) - 3- (4-chlorophenyl) -8-methyl-8-azabicyclo [3.2.1] oct-2-ene or
(+) - 3- (3,4-dichlorophenyl) -8-azabicyclo [3.2.1] oct-2-ene
or a pharmaceutically acceptable addition salt thereof.
(+)-3-(3,4-дихлорфенил)-8-метил-8-азабицикло[3.2.1]окт-2-ен,
(+)-3-(4-хлорфенил)-8-метил-8-азабицикло[3.2.1]окт-2-ен или
(+)-3-(3,4-дихлорфенил)-8-азабицикло[3.2.1]окт-2-ен
либо их фармацевтически приемлемую соль присоединения.7. The method according to paragraphs. 4-6, characterized in that the compound used is
(+) - 3- (3,4-dichlorophenyl) -8-methyl-8-azabicyclo [3.2.1] oct-2-ene,
(+) - 3- (4-chlorophenyl) -8-methyl-8-azabicyclo [3.2.1] oct-2-ene or
(+) - 3- (3,4-dichlorophenyl) -8-azabicyclo [3.2.1] oct-2-ene
or their pharmaceutically acceptable salt accession.
где R и R4 такие, как определено в п.1, после чего возможно образуют его фармацевтически приемлемую соль присоединения.11. The method of producing compounds according to claim 1, wherein the compound having the formula
where R and R 4 are as defined in claim 1, after which it is possible to form its pharmaceutically acceptable addition salt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1156/95 | 1995-10-13 | ||
DK115695 | 1995-10-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98105169A true RU98105169A (en) | 1999-12-20 |
RU2157372C2 RU2157372C2 (en) | 2000-10-10 |
Family
ID=8101642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98105169/04A RU2157372C2 (en) | 1995-10-13 | 1996-10-11 | Derivatives of 8-azabicyclo[3,2,1]oct-2-ene, method of their synthesis, pharmaceutical composition, method of drug preparing, methods of inhibition of reuptake of monoamine neuromediating agent, especially, serotonin |
Country Status (24)
Country | Link |
---|---|
US (1) | US6100275A (en) |
EP (1) | EP0859777B1 (en) |
JP (1) | JP3462505B2 (en) |
KR (1) | KR100274829B1 (en) |
CN (1) | CN1083840C (en) |
AT (1) | ATE362931T1 (en) |
AU (1) | AU709327B2 (en) |
BR (1) | BR9610960A (en) |
CA (1) | CA2233541C (en) |
CZ (1) | CZ285093B6 (en) |
DE (1) | DE69637097T2 (en) |
DK (1) | DK0859777T3 (en) |
EE (1) | EE03446B1 (en) |
HU (1) | HUP9802433A3 (en) |
IL (1) | IL123583A (en) |
IS (1) | IS4681A (en) |
NO (1) | NO980919L (en) |
NZ (1) | NZ320216A (en) |
PL (1) | PL185357B1 (en) |
RU (1) | RU2157372C2 (en) |
SK (1) | SK283425B6 (en) |
TR (1) | TR199800628T2 (en) |
UA (1) | UA63894C2 (en) |
WO (1) | WO1997013770A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9510459D0 (en) | 1995-05-24 | 1995-07-19 | Zeneca Ltd | Bicyclic amines |
JP2000510144A (en) * | 1996-05-13 | 2000-08-08 | ゼネカ リミテッド | Bicyclic amines as insecticides |
GB9623944D0 (en) * | 1996-11-15 | 1997-01-08 | Zeneca Ltd | Bicyclic amine derivatives |
GB9624114D0 (en) * | 1996-11-20 | 1997-01-08 | Zeneca Ltd | Pesticidal bicyclic amine derivatives |
TW370451B (en) | 1996-11-26 | 1999-09-21 | Zeneca Ltd | Bicyclic amine derivatives |
GB9624611D0 (en) | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Bicyclic amine compounds |
GB9706222D0 (en) * | 1997-03-26 | 1997-05-14 | Zeneca Ltd | Bicyclic amine derivatives |
BR9809697A (en) | 1997-05-30 | 2000-07-11 | Neurosearch As | Compound, use, and process for the preparation thereof, pharmaceutical composition, and, process for treating a disease of a live animal body, including a human |
GB9726033D0 (en) | 1997-12-09 | 1998-02-04 | Zeneca Ltd | Chemical process |
TWI221842B (en) * | 1997-12-11 | 2004-10-11 | Syngenta Ltd | Process for the preparation of 8-azabicyclo(3.2.1)octane derivatives |
AU2609999A (en) * | 1998-01-28 | 1999-08-16 | Neurosearch A/S | 8-azabicyclo(3.2.1)oct-2-ene derivatives in labelled and use of 8-azabicyclo(3.2.1)oct-2-ene derivatives in labelled and unlabelled form |
US6403605B1 (en) * | 1998-05-29 | 2002-06-11 | Queen's University At Kingston | Methods for the normalization of sexual response and amelioration of long term genital tissue degradation |
CA2335336A1 (en) * | 1998-06-19 | 1999-12-23 | James Edmund Audia | Inhibition of serotonin reuptake |
EP1133494B1 (en) | 1998-11-27 | 2004-02-18 | Neurosearch A/S | 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
EP1149095B1 (en) * | 1999-01-28 | 2004-01-21 | Neurosearch A/S | Novel azabicyclo derivatives and their use |
JP2002538134A (en) * | 1999-03-01 | 2002-11-12 | ファイザー・インク | 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful for therapy |
EA004101B1 (en) | 1999-09-03 | 2003-12-25 | Эли Лилли Энд Компани | Using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
US6835733B2 (en) | 1999-12-20 | 2004-12-28 | Eli Lilly And Company | Tropane linked benzofuran derivatives |
CA2409644A1 (en) | 2000-05-25 | 2001-11-29 | Targacept, Inc. | Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
US6667314B2 (en) | 2000-05-26 | 2003-12-23 | Pfizer, Inc. | Tropane derivatives useful in therapy |
US6579878B1 (en) | 2000-07-07 | 2003-06-17 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
US6624167B1 (en) | 2000-08-04 | 2003-09-23 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
EP1757600A2 (en) * | 2000-10-13 | 2007-02-28 | NeuroSearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
DE60231386D1 (en) | 2001-04-09 | 2009-04-16 | Neurosearch As | ADENOSINE A2A RECEPTOR ANTAGONISTS IN COMBINATION WITH COMPOUNDS WITH NEUROTROPHIC ACTIVITY IN THE TREATMENT OF MORBUS PARKINSON |
AR035898A1 (en) | 2001-05-25 | 2004-07-21 | Wyeth Corp | ARIL-8-AZABICICLO [3.2.1] OCTANS, A PROCESS FOR THEIR PREPARATION, A FORMULATION AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DEPRESSION |
MXPA04010965A (en) * | 2002-05-07 | 2005-01-25 | Neurosearch As | Novel azacyclic ethynyl derivatives. |
WO2006108789A1 (en) * | 2005-04-08 | 2006-10-19 | Neurosearch A/S | Novel enantiomers and their use as monoamine neurotransmitter re-uptake inhibitors |
TW200744590A (en) * | 2005-09-01 | 2007-12-16 | Neurosearch As | Novel compounds |
KR100812499B1 (en) * | 2006-10-16 | 2008-03-11 | 이도훈 | Anticonvulsant |
TWI415850B (en) * | 2007-07-20 | 2013-11-21 | Theravance Inc | Process for preparing an intermediate to mu opioid receptor antagonists |
JP2011513354A (en) * | 2008-03-05 | 2011-04-28 | ノイロサーチ アクティーゼルスカブ | Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter reuptake inhibitors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB247886A (en) * | 1925-11-02 | 1926-02-25 | Thomas Stewart Hamilton | Improvements in attachments for leaf springs |
US3133073A (en) * | 1959-12-10 | 1964-05-12 | Sterling Drug Inc | 3-aryl-1, 5-iminocycloalkanes and preparation thereof |
US3657257A (en) * | 1970-08-31 | 1972-04-18 | Robins Co Inc A H | 3-aryl-8-carbamoyl nortropanes |
US4180669A (en) * | 1976-12-13 | 1979-12-25 | Abbott Laboratories | 2-(N-phenethyl-4-piperidino)-5-pentyl resorcinol |
US4132710A (en) * | 1976-12-20 | 1979-01-02 | Ayerst, Mckenna And Harrison, Ltd. | [2]Benzopyrano[3,4-c]pyridines and process therefor |
DK75680A (en) * | 1979-02-22 | 1980-08-23 | Wellcome Found | PROCEDURE FOR THE PREPARATION OF 1-SUBSTITUTED IMIDAZOLS |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
DK198590D0 (en) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
GB9019973D0 (en) * | 1990-09-12 | 1990-10-24 | Wyeth John & Brother Ltd | Azabicyclic derivatives |
FI111367B (en) * | 1991-02-04 | 2003-07-15 | Aventis Pharma Inc | Process for the preparation of therapeutically useful N- (aryloxyalkyl) heteroaryl-8-azabicyclo [3.2.1] octane derivatives and intermediates used in the process |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
DE4200145A1 (en) * | 1992-01-07 | 1993-07-08 | Kali Chemie Pharma Gmbh | 7,10-EPOXY-OXACYCLODODANE DERIVATIVES, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
AU672052B2 (en) * | 1992-12-23 | 1996-09-19 | Neurosearch A/S | Antidepressant and antiparkinsonian compounds |
DK154192D0 (en) * | 1992-12-23 | 1992-12-23 | Neurosearch As | HETEROCYCLIC COMPOUNDS |
CA2163095A1 (en) * | 1993-05-18 | 1994-11-24 | Huw M. L. Davies | Treatment process with biologically active tropane derivatives |
EE03877B1 (en) * | 1994-04-19 | 2002-10-15 | Neurosearch A/S | Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
US5731317A (en) * | 1995-03-10 | 1998-03-24 | Merck & Co., Inc. | Bridged piperidines promote release of growth hormone |
-
1996
- 1996-10-11 TR TR1998/00628T patent/TR199800628T2/en unknown
- 1996-10-11 EE EE9800062A patent/EE03446B1/en not_active IP Right Cessation
- 1996-10-11 JP JP51472697A patent/JP3462505B2/en not_active Expired - Fee Related
- 1996-10-11 DE DE69637097T patent/DE69637097T2/en not_active Expired - Lifetime
- 1996-10-11 RU RU98105169/04A patent/RU2157372C2/en not_active IP Right Cessation
- 1996-10-11 PL PL96326195A patent/PL185357B1/en not_active IP Right Cessation
- 1996-10-11 EP EP96934662A patent/EP0859777B1/en not_active Expired - Lifetime
- 1996-10-11 CN CN96197566A patent/CN1083840C/en not_active Expired - Fee Related
- 1996-10-11 NZ NZ320216A patent/NZ320216A/en not_active IP Right Cessation
- 1996-10-11 BR BR9610960A patent/BR9610960A/en not_active Application Discontinuation
- 1996-10-11 AT AT96934662T patent/ATE362931T1/en active
- 1996-10-11 US US09/043,294 patent/US6100275A/en not_active Expired - Fee Related
- 1996-10-11 WO PCT/EP1996/004449 patent/WO1997013770A1/en active IP Right Grant
- 1996-10-11 CA CA002233541A patent/CA2233541C/en not_active Expired - Fee Related
- 1996-10-11 DK DK96934662T patent/DK0859777T3/en active
- 1996-10-11 HU HU9802433A patent/HUP9802433A3/en unknown
- 1996-10-11 CZ CZ98758A patent/CZ285093B6/en not_active IP Right Cessation
- 1996-10-11 AU AU72917/96A patent/AU709327B2/en not_active Ceased
- 1996-10-11 IL IL12358396A patent/IL123583A/en not_active IP Right Cessation
- 1996-10-11 SK SK287-98A patent/SK283425B6/en unknown
- 1996-10-11 KR KR1019980702103A patent/KR100274829B1/en not_active IP Right Cessation
- 1996-11-10 UA UA98031543A patent/UA63894C2/en unknown
-
1998
- 1998-03-03 NO NO19980919A patent/NO980919L/en not_active Application Discontinuation
- 1998-03-04 IS IS4681A patent/IS4681A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98105169A (en) | DERIVATIVES 8-AZABICYCLO [3.2.1] OCT-2-ENA, THEIR RECEIVING AND APPLICATION | |
RU98117314A (en) | TROPANIC DERIVATIVES, THEIR PRODUCTION AND APPLICATION | |
KR100236666B1 (en) | Compositions comprising a tramadol and any of codeine, oxycodone or hydrocodone, and their use | |
RU93058534A (en) | APPLICATION OF TETRAHYDROCARBAZOLE DERIVATIVES AS 5-NT * 001 RECEPTOR ANTAGONISTS, TETRAHYDROCARBAZOLE DERIVATIVES, METHOD FOR PRODUCING THERAPY, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION | |
KR940013555A (en) | Alkyl Substituted Heterocyclic Compounds | |
JP2020528431A5 (en) | ||
RU98110007A (en) | CONDENSED TROPANE DERIVATIVES AS NEURAL MEDIATOR REVERSE INHIBITORS | |
RU2018130727A (en) | ORGANIC COMPOUNDS | |
RU2006131132A (en) | 1,3,5, -TRISubstituted derivatives of 4,5-dihydro-1H-pyrazole possessing CB1-antagonistic activity | |
US20070249681A1 (en) | Bupivacaines | |
UA41254C2 (en) | TETRAHYDROCARBAZOLE DERIVATIVE OR ITS SALT, SOLVATE OR HYDRATE AS AN AGONIST OF 5-HT <sub> 1 </sub> -SILE RECEPTOR, METHOD OF THEIR DETERMINATION | |
EP1928451B1 (en) | Methods for treating substance-related disorders | |
US20070105884A1 (en) | Opiate analogs selective for the delta-opioid receptor | |
JP2003530345A (en) | Pharmaceutical composition for the treatment of acute, chronic pain and / or neuropathic pain and migraine | |
BR0312216A (en) | Compound, process for producing a compound, pharmaceutical composition, use of the compound, method for treating a subject suffering from a disease or condition and product combination | |
JP2003514818A (en) | New uses and new N-azabicyclo-amide derivatives | |
CN101300006B (en) | MAO-B inhibitors useful for treating obesity | |
CH616668A5 (en) | ||
IS4681A (en) | 8-azabicyclo (3.2.1) oct-2-ene derivatives, their preparation and use | |
RU96121937A (en) | DERIVATIVES OF TROPAN-2-ALDOXIM AS REQUIRED INHIBITORS OF REVERSE CAPTURE OF NEUROTREMITTERS | |
JP2005508872A5 (en) | ||
JPH10316567A (en) | Nk-1 receptor antagonist for treatment of symptom of hypersensitive intestinal syndrome | |
ATE403426T1 (en) | OPIOID RECEPTOR ACTIVE 4-(3-HYDROXYPHENYL) OR 4-(3-ALKOXYPHENYL)-1,2,4-TRIAZOLE COMPOUNDS | |
CN101262867A (en) | MAO-B inhibitors useful for treating obesity | |
CN105209445B (en) | The method for treating dyskinesia and associated conditions |